I
t is increasingly clear that cell-signaling systems serve multiple functions. Signaling molecules that play a highly visible functional role in muscle by regulating intracellular Ca 2ϩ ([Ca 2ϩ ] i ) homeostasis and contraction are also coupled to the genetic machinery of the cell and thereby shape the repertoire of expressed proteins. Our emerging understanding of excitation-contraction coupling (ECC) follows this theme (Figure) 4 The situation in cardiomyocytes seems to be somewhat simpler, as only the ryanodine receptors have a demonstrated role in ECC. ECC is mainly controlled by short-term signaling events to regulate the continuous ebb and flow of activator [Ca 2ϩ ] i that is necessary for cycling myofilament crossbridge formation. Nevertheless, the molecular machinery of ECC also regulates the transcriptional activity of the cell over a much longer time scale by a process termed excitationtranscription coupling (ETC). 5 An important question in signal transduction is how ETC mechanisms in muscle screen out the constant [Ca 2ϩ ] i fluctuations to deliver cogent instructions to the nucleus. One answer to this question is that transcription factors have distinct response characteristics that may refine the message content of [Ca 2ϩ ] i oscillations. In B lymphocytes, the transcription regulatory proteins nuclear factor-B, JNK, and NFAT are differentially activated by brief Ca 2ϩ signals of high magnitude compared with prolonged Ca 2ϩ signals of lower magnitude. 6 Location is also important. Regulatory proteins may be anchored (by specific binding proteins) 7 or confined to distinct intracellular domains (eg, the nucleus) 8 that experience very different Ca 2ϩ signals than those measured in the bulk cytoplasm. Connections are essential for success. Ca 2ϩ entry through L-type Ca 2ϩ channels seems to constitute a "privileged" pathway that can selectively couple to the Ca 2ϩ -binding protein calmodulin for signaling Ca 2ϩ -dependent transcriptional events in neurons 9 or for excitationsecretion coupling in chromaffin cells. 10 These possibilities are only now beginning to be explored in the cardiovascular system.
To understand how we might manipulate the connections between ECC and ECT, it is necessary to know where and how these 2 systems interact. Ca 2ϩ -activated kinases and phosphatases are important linking molecules that can coordinate interactions between ECC and ETC. After activation by increased [Ca 2ϩ ] i , these enzymes alter the phosphorylation state of Ca 2ϩ regulatory protein complexes to directly modulate ECC and act on Ca 2ϩ -dependent transcription factors that "tune" ECC over a longer time frame by affecting expression of ECC regulatory proteins. This proposed linkage has important implications for disease: cardiomyopathy has been associated with disordered expression of several key Ca 2ϩ homeostatic proteins, including the Na ϩ -Ca 2ϩ exchanger SR Ca 2ϩ ATPase 11, 12 and numerous sarcomeric proteins. 13 Expression of a constitutively active form of the Ca 2ϩ and calmodulin-activated phosphatase calcineurin causes profound hypertrophy and dilated cardiomyopathy, 14 whereas constitutive expression of calmodulin kinase (CaMK) IV results in a hypertrophic phenotype with less pronounced systolic dysfunction (Eric Olson, personal communication, November 1999). Expression of some CaMK isoforms is increased in human heart failure 8 and atrial fibrillation, 15 2 diseases linked to heart rate and Ca 2ϩ -dependent electrical remodeling. Electrical remodeling in heart failure is associated with action potential prolongation 16 that may itself be an important stimulus for CaMK activation 17 by increasing the duration of the [Ca 2ϩ ] i transient. 18 CaMK also participates in ECC by modulating Ca 2ϩ entry through L-type Ca 2ϩ channels 19 and by regulating uptake 20 and release of Ca 2ϩ from intracellular stores. [21] [22] [23] These examples may illustrate important consequences of pathophysiological ECC-ETC interactions.
The study by Cartin et al 24 in this issue of Circulation Research links the phosphorylation of the cAMP response element binding (CREB) protein and consequent induction of c-fos to CaMK-dependent and Ca 2ϩ -independent signal transduction. In addition to enhancing our conceptual understanding of the ECC-ETC link in vascular smooth muscle, this study nicely highlights one important experimental issue in signaling research: the details of cellular ultrastructure matter. Cartin et al were the first to report the paradoxical effect of suppressing Ca 2ϩ sparks in vascular smooth muscle 25 of ECC and ETC are dependent on specific cellular environments. One of the important questions that follow from the present work is the identity of the CaMK type responsible for CREB phosphorylation. Cartin et al found that both CaMK II and IV were present in vascular smooth muscle. CaMK IV is thought to be predominantly nuclear, whereas CaMK II may exist in the cytoplasm or nucleus, depending on the isoform mix of the heteromultimerized holoenzyme, 26 and both types can phosphorylate CREB. The consequences of CREB phosphorylation by CaMK II may be inhibitory, because CaMK II can effectively phosphorylate a second negative regulatory site (Ser142). However, both CaMK II and IV can phosphorylate the activating site (Ser133), 27 suggesting that CaMK IV may have determined c-fos levels in these experiments. Details of the probable counterregulation of CaMK-mediated CREB phosphorylation by phosphatases in vascular smooth muscle also remain to be elucidated. Finally, linkage of ECC and ETC by kinases and phosphatases offers the possibility of novel therapeutic tools to address cardiovascular disease.
Interaction of ECC (solid arrows) and ECT (dashed arrows) may occur at different levels within the cell. The cell membrane (1) 4 Release of Ca 2ϩ from intracellular stores allows contraction (ECC) and activation of Ca 2ϩ -dependent phosphatases and kinases (ECC and ETC) and may regulate the nuclear pore protein complex (ETC) (3). 31 Ca 2ϩ -dependent regulation of the nuclear pore is likely to be important for determining entry of signaling molecules in transit to the nucleus and regulating egress of mRNA to the cytoplasm. 32, 33 Activation of Ca 2ϩ -dependent transcription factors in the nucleus (4) initiates production of new proteins for regulation of Ca 2ϩ entry and uptake and release of Ca 2ϩ from intracellular stores. 34 
